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Abstract
The prevalence of severe obesity, defined as body mass index (BMI) $35.0 kg/m2, is rising rapidly. Given the
disproportionately high health burden and healthcare costs associated with this condition, understanding the underlying
aetiology, including predisposing genetic factors, is a biomedical research priority. Previous studies have suggested that
severe obesity represents an extreme tail of the population BMI variation, reflecting shared genetic factors operating across
the spectrum. Here, we sought to determine whether a panel of 32 known common obesity-susceptibility variants
contribute to severe obesity in patients (n = 1,003, mean BMI 48.468.1 kg/m2) attending bariatric surgery clinics in two
European centres. We examined the effects of these 32 common variants on obesity risk and BMI, both as individual markers
and in combination as a genetic risk score, in a comparison with normal-weight controls (n = 1,809, BMI 18.0–24.9 kg/m2);
an approach which, to our knowledge, has not been previously undertaken in the setting of a bariatric clinic. We found
strong associations with severe obesity for SNP rs9939609 within the FTO gene (P = 9.361028) and SNP rs2815752 near the
NEGR1 gene (P = 3.661024), and directionally consistent nominal associations (P,0.05) for 12 other SNPs. The genetic risk
score associated with severe obesity (P = 8.3610211) but, within the bariatric cohort, this score did not associate with BMI
itself (P = 0.264). Our results show significant effects of individual BMI-associated common variants within a relatively small
sample size of bariatric patients. Furthermore, the burden of such low-penetrant risk alleles contributes to severe obesity in
this population. Our findings support that severe obesity observed in bariatric patients represents an extreme tail of the
population BMI variation. Moreover, future genetic studies focused on bariatric patients may provide valuable insights into
the pathogenesis of obesity at a population level.
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Introduction
Obesity is a serious and increasing threat to the health of
populations globally. The high burden of obesity-related co-
morbidities, such as type 2 diabetes, cardiovascular disease and
certain cancers, heighten the severity of this obesity crisis.
Globally, in 2008 over 200 million men and almost 300 million
women were obese, defined by body mass index (BMI $30 kg/
m2), which represents an approximate doubling of the prevalence
of obesity since 1980 [1]. Alarmingly, the prevalence of severe
obesity (BMI $35 kg/m2) continue to rise rapidly in westernised
societies [2,3,4], despite a flattening in the trend for levels of
overall obesity [5]. Given the disproportionately higher health
burden and healthcare costs associated with severe obesity [6],
understanding the underlying mechanisms, including genetic
factors, is a biomedical research priority.
BMI is heavily dependent on genetic susceptibility as demon-
strated by twin and adoption studies [7,8]. Furthermore, in the
quest to elucidate the biological basis of obesity, genome wide
association studies (GWAS) using single nucleotide polymorphisms
(SNPs) have identified more than 40 genetic variants to date that
are associated with BMI or risk for obesity (defined as BMI
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$30 kg/m2) [9,10,11]. The finding that multiple common
variants have effects on the risk of being obese invokes the
‘common disease, common variant’ hypothesis of obesity [12,13].
However, the considerable gap between the 2% of variance
attributable to common variants and the much higher estimated
heritability raises questions over what constitutes the genetic basis
of obesity [12,13]. Previous studies have suggested that individuals
who have extreme obese phenotypes, such as early onset (BMI
$95th percentile achieved before the age of 10–18 years old)
[14,15] or severe adult obesity (BMI $35.0 kg/m2) [16], represent
an extreme tail of the population BMI variation, with a higher
burden of shared genetic factors [17]. Alternatively, extreme
obesity may be viewed as a separate entity with distinct underlying
genetic factors [18]. Previous GWAS reports for severe adult
obesity case-control samples identified associations only with
SNPS within the intronic FTO locus [16,19], consistent with the
robust association of these SNPs with BMI in the general
population [10]. In contrast, other GWAS evaluating early onset
extreme obesity detected loci distinct from those identified in the
meta-analysis of adult BMI [20,21,22]. Importantly, a recent
genome-wide analysis for loci associated with clinical classes of
obesity and extreme BMI tails [11], drawn from populations
within the prior Genetic Investigation of ANthropometric Traits
(GIANT) meta-analysis of adult BMI, detected no new loci
associated with class 3 obesity (BMI $40 kg/m2), in addition to
those uncovered in the original meta-analysis. While two new loci
were found to be associated with class 2 obesity (BMI 35.0–
39.9 kg/m2), this study provides strong evidence that the majority
of common BMI-increasing variants continue to have effects
across the full BMI spectrum.
Bariatric or weight-loss surgery is indicated for patients with a
BMI $40.0 kg/m2 or $35.0 kg/m2 in the presence of at least one
obesity-related comorbidity, and currently represents the most
effective treatment for patients with severe obesity [23]. In light of
the marked health benefits of bariatric surgery, the number of
patients being referred for bariatric surgery assessment is
increasing, with over 340,000 bariatric procedures undertaken in
2011 [24]. The assessment of patients in bariatric surgery centres
thus offers an opportunity to undertake genetic studies in a
population at the upper tail of the BMI spectrum.
Therefore, we investigated whether 32 known common obesity-
susceptibility variants are enriched in a cohort of patients with
severe obesity attending a bariatric surgical assessment clinic,
compared with normal-weight (BMI 18.0–24.9 kg/m2) controls.
We found that a genetic risk score, calculated based on all 32
genotyped SNPs, is associated with severe obesity but there was no
significant effect of the genetic risk score on BMI within the
bariatric cohort.
Methods
Study Population and Anthropometric Measures
Patients were recruited from two bariatric centres; the
University College London Hospitals (UCLH) Centre for
Weight-loss, Metabolic and Endocrine Surgery, London, UK
and the University Hospital of Pisa (UHP), Pisa, Italy. Individuals
of European descent were included in the analyses in order to
facilitate comparison with a UK population-based control group.
Patients with a BMI $35.0 kg/m2 who donated a peripheral
blood sample for DNA analysis were recruited to the study. At the
UCLH Centre, 585 patients who attended bariatric surgery clinics
were recruited between October 2009 and October 2012. Of these
585 patients, 26 were excluded due to incomplete clinical data
(n = 11), absence of genotyping (n= 6), unsuccessful genotyping
(n= 4) or a documented BMI of ,35.0 kg/m2 (n= 5), which
resulted in a total of 559 patients from the UCLH centre being
included. 36 UCLH patients, who had undergone previous
bariatric surgery for treatment of severe obesity (BMI $35.0 kg/
m2) at other bariatric centres, were included in the case-control
analysis but not in the analysis for SNP effects on BMI. 444 Italian
patients who attended to the Obesity Centre at the Endocrinology
Unit of the University Hospital of Pisa, Italy, from January 2003 to
December 2011, for evaluation prior to bariatric surgery, were
recruited to the study. Thus, 1,003 samples were available for the
case-control analysis and 967 (excluding n= 36 patients who had
previous bariatric surgery) were included in the within-group
analysis. BMI was calculated from the weight and height
measurements recorded at the first visit to the bariatric clinic.
Weight was measured using the Walkthrough Platform A12SS
Stainless Steel Indicator. Height was measured using a wall-
mounted digital stadiometer. Demographic and comorbidity data
were collected by means of an electronic clinical data record. The
National Health Service Research Ethics Committee approved the
research protocol (ID#09/H0715/65) and all participants pro-
vided written informed consent. The control group was comprised
of normal-weight population-based controls from the British 1958
Birth Cohort (B58C) who were previously genotyped either as part
of the Wellcome Trust Case Control Consortium 2 [25] or
another related genotyping effort [26]. From a total of 5,382 B58C
reference samples, we selected individuals with BMI in the normal
range (18.0–24.9 kg/m2, mean 22.861.6 kg/m2), amounting to
1,809 normal-weight controls, 64% of whom were female and
36% male. B58C controls had anthropometric data measured
during a biomedical examination undertaken at the age of 44–45
years [27].
DNA Extraction and Quantification of Bariatric Surgery
Case Samples
All DNA extractions from peripheral blood samples were
performed using the QIAamp DNA Blood Midi Kit (Qiagen)
according to the manufacturer’s instructions. DNA concentration
and purity were determined with UV spectrophotometry (Nano-
drop) measuring the spectrophotometric absorbance ratios of
260 nm/280 nm. High quality DNA was considered to have an
A260/A280 ratio of 1.85 - 2.10. All genomic DNA was diluted to a
final concentration of 5 ng/ml.
SNP Genotyping of Bariatric Surgery Case Samples
30 single nucleotide polymorphisms (SNPs) corresponding to
loci identified in the GIANT meta-analysis of adult BMI [10] were
genotyped. Genotyping was not successful for two other SNPs,
rs12444979 near GPRC5B and rs4836133 near ZNF608. Two
further SNPs, corresponding to the additional loci near HOXB5
and OLFM4 uncovered in a meta-analysis of childhood severe
obesity [14] and which also yielded directionally consistent
associations in the meta-analysis of adult BMI [10], were also
genotyped. Of note, the FTO SNP genotyped was rs9939609,
which was the SNP reported in the first GIANT GWAS [9] and is
in strong to complete linkage disequilibrium with other reported
intronic FTO SNPs [28]. Genotyping of bariatric patients was
performed by KBioscience (Hertfordshire, UK). SNPs were
genotyped using the KASP (KBioscience Competitive Allele-
Specific PCR) SNP genotyping system (www.lgcgenomics.com/
genotyping/kasp-genotyping-reagents/). The following quality
criteria were applied to both bariatric cases and B58C control
samples: HWE p-value .0.0001, genotype callrate .95%, and
sample callrate .90%. Blind duplicates were used to detect
possible DNA mixup.
Genetics of Obesity in Bariatric Surgery Patients
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Statistical Analysis
Statistical analyses were performed using the programs PLINK
[29], SNPTEST [30], and R software environment [31]. Logistic
regression analyses were performed using an additive genetic
model to evaluate the difference between the normal-weight
control group (n= 1,809) and the sample of bariatric surgery
patients (n = 1,003). Additionally, linear regression analyses with
an additive genetic model were performed for BMI within the
bariatric sample-set alone (n = 967, excluding n= 36 patients who
had previous bariatric surgery), firstly using standardized BMI
values (see Model S1 in File S1 for standardization formula) in
order to compare effect sizes within the bariatric cohort with the
known effect sizes derived from inverse standardized BMI values
in the published meta-analysis [10], and secondly, using unstan-
dardized BMI values in considering the BMI distribution of the
bariatric cohort sample-set. To compare between the reference
effect sizes from the published meta-analysis [10] and effect sizes in
the bariatric cohort, we used a standard t-test. Secondary logistic
and linear regression analyses were performed using both
dominant and recessive models. Power analysis for single marker
effects, performed with a genetic power calculator (http://pngu.
mgh.harvard.edu/˜purcell/cgi-bin/cc2k.cgi) taking a trait preva-
lence of 4%, a risk allele frequency of 20%, and p-value threshold
adjusted for 32 independent samples (a=0.05/32= 0.00132),
showed that power estimates for genotype relative risks of 1.1,
1.15, 1.2 and 1.25 were 4.2%, 15.1%, 36.9% and 62.9%
respectively. All analyses were adjusted for gender, age and
country of origin. A previous analysis demonstrated that the
common BMI-increasing SNPs do not appear to have strong allele
frequency differences across five diverse European populations,
including the B58C cohort and an Italian cohort [10], therefore a
specific Italian control sample-set was not sought.
Multiple marker analyses were performed with PLINK [29]
using genetic scores calculated from all 32 genotyped markers with
their relative weight based on their effect sizes in the published
meta-analysis [10] (Model S2 in File S1). Linear regression model
in R was used for evaluating the predictive value of the genetic
score in relation to BMI within the bariatric cohort and logistic
regression was used to determine the extent to which genetic
scores distinguished between the normal-weight control and
bariatric cohort groups.
Results
A total of 1,003 patients attending a bariatric surgery assessment
clinic were included in the case-control analyses (see Table 1 for
baseline demographic and anthropometric characteristics). Firstly,
we undertook a comparison of the effects of BMI-raising SNPs in
the normal-weight control (n = 1,809) and the bariatric surgery
(n = 1,003) groups to determine whether known BMI-increasing
SNPs are associated with severe obesity in our cohort. We found
associations for SNP rs9939609 within the FTO gene
(P=9.361028) and SNP rs2815752 near the NEGR1 gene
(P= 3.661024). Directionally consistent nominal associations were
also detected for SNPs at the FAIM2, TMEM18, PRKD1 and
MC4R(B) loci (P,0.01), and at the SLC39A8, TNNI3K, OLFM4,
LRP1B, KCTD15, TFAP2B, GNPDA2 and SEC16B loci (P,0.05)
(Table 2). Analysis of SNPs at the other 18 loci did not reveal any
evidence of association. However, 9 of these 18 SNPs had effects
directionally consistent with the GIANT meta-analysis results
(Table 2). Secondary analyses using both dominant and recessive
models revealed similar results to the additive model (Table S1 in
File S1). Stronger associations were found for six SNPs using the
dominant model and for two SNPs using the recessive model
(Table S1 in File S1). Upon combining all 32 genotyped SNPs into
a genetic risk score, we found a significant difference in the
average risk score between normal-weight control group and the
bariatric surgery group (P= 8.3610211, adjusted R2= 0.0043)
(Figure 1). Comparison of the effects of BMI-associated SNPs in
patients in specific BMI categories in the bariatric cohort
(,40.0 kg/m2, 40.0–44.9 kg/m2, 45.0–49.9 kg/m2, 50.0–
59.9 kg/m2, $60.0 kg/m2) and the normal-weight control group
revealed that both the strongest effects for the SNP rs9939609
within the FTO gene (b= 1.0860.23, P= 3.461026) and the
weakest effects for the SNP rs2815752 near the NEGR1 gene
(b= 0.0260.22, P= 0.9) were in the $60.0 kg/m2 BMI category
(Table 3). In order to place our findings in the context of the
recent GIANT-extremes results [11], we compared the effects of
the BMI-increasing SNPs on odds of severe obesity in our study
with those from the GIANT-extremes analyses and detected no
significant differences (Figure 2).
Next, we examined the association of the BMI-increasing SNPs
with BMI within the bariatric surgery cohort alone (n = 967,
excluding n= 36 patients who had previous bariatric surgery).
Nominal associations with BMI were found only for SNP
rs9939609 within the FTO gene (P= 0.01, b= 0.1160.04) and
with SNP rs2815752 near the NEGR1 gene, however, paradox-
ically, there was a negative effect direction for the NEGR1 locus
effect allele (P= 0.03, b=20.160.05). Furthermore, the 32 SNP
genetic risk score did not distinguish between BMI values within
bariatric surgery patients (P=0.264, adjusted R2= 0.0045). We
then undertook linear analyses, using both standardized and
unstandardized BMI values, to compare the effects on BMI within
the bariatric surgery group with previously published data from
the GIANT meta-analysis of adult BMI (GIANT-BMI) [10].
These analyses revealed no significant differences between the
compared effect sizes (Figure 3A–B).
Discussion
In a comparison with normal-weight controls, our analysis of
genotype data from European adults with severe obesity attending
two bariatric surgery centres has again demonstrated a strong
association of the intronic FTO SNP rs9939609 with severe
obesity. Furthermore, we have shown that a further 13 of the other
31 obesity susceptibility loci that we investigated are at least
nominally associated with severe obesity in this cohort of patients
being assessed for bariatric surgery. Combination of the 32 SNPs
into a genetic risk score convincingly distinguished between
normal BMI controls and severely obese patients, which further
highlights the influence of common variants on the presence of
severe obesity in adults. Our study is, to our knowledge, the first to
perform such a comprehensive polygene risk score in a cohort of
patients with severe obesity specifically in the setting of a bariatric
surgery clinic, ranging from complicated class 2 obesity (BMI
35.0–39.9 kg/m2 in the presence of at least one obesity-related
comorbidity) to the super super-obese category (BMI $60.0 kg/
m2) (Table 3). Our results suggest that severe obesity represents an
extreme of the continuum of BMI variance in the general
population, consistent with the results from the recent GIANT-
extremes analysis [11].
The methodological approach relating to the polygene risk
score represents a novel aspect of our study. While one previous
case-control GWAS also specifically studied subjects with severe
obesity (mean BMI 50.468.1 kg/m2), who were attending a
bariatric surgery centre, there are important differences between
our study design and that of the Cotsapas et al. study [16]. After
finding a genome-wide association with severe obesity for the FTO
Genetics of Obesity in Bariatric Surgery Patients
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locus, the investigators then evaluated 12 of the known BMI-
associated loci for association with severe obesity. They found that
there was a higher burden of risk alleles in patients with severe
obesity than in controls and in the more extreme half of BMI
distribution within this bariatric cohort [16]. In contrast, we
employed a more comprehensive analysis evaluating the contri-
bution of 32 common BMI-increasing SNPs to severe obesity.
Rather than using the approach of comparing number of risk
alleles as in the Cotsapas et al. study, the genetic scores in our study
were calculated based on the relative weight of the SNP effect sizes
reported in GIANT-BMI meta-analysis. Furthermore, our study
employed a comparison with normal-weight controls, whereas the
anthropometric data of the controls in the Cotsapas et al. study
were not available. Previous studies have used such risk scores in
the setting of extremes of obesity, with varying results, however
these studies employed a more limited panel of SNPs
[15,16,22,32]. Nevertheless, the polygenetic approach employed
in the GIANT-extremes analysis demonstrates the utility of
combining multiple common variants, including those with effect
size ,0.05, in explaining BMI variance [11].
Our results are consistent with previous studies demonstrating
that SNPs in the first intron of FTO bear the strongest association
with obesity, of the known BMI-raising SNPs [10,16,19], and also
are strongly associated with extremes of obesity
[11,16,19,20,22,33,34]. We found that the FTO SNP rs9939609
was also nominally associated with BMI within the severe obese
cohort. Furthermore, among the 32 loci, the FTO locus held the
strongest association and largest effect size in patients with a BMI
$60.0 kg/m2. Taken together, these findings suggest that FTO
variants retain an important contributory role in the pathogenesis
of obesity at increasing levels of severe obesity. The robust
association of the FTO locus with severe obesity is likely to be
mediated through well-documented effects on increasing energy
intake [35], and it is highly likely that the altered function in the
FTO gene itself is mechanistically responsible for the phenotypic
effects [36]. However, the mechanisms underlying the FTO risk
allele phenotype and the SNP effects on FTO gene function remain
to be fully explored. Interestingly, in this regard, recent evidence
suggests that the functional effects of the FTO SNP rs9939609 may
be mediated through differential methylation of FTO itself [37]
and myriad other genes [38].
Along with the strong association of the FTO locus, we also
detected association of the SNP rs2815752 near the NEGR1 gene
with severe obesity. This NEGR1 SNP ranked among the top four
most strongly associated with extremes of obesity of all 32 BMI-
associated loci in the GIANT analyses [10,11]. Interestingly, we
found that the NEGR1 risk allele had a negative effect direction in
relation to BMI within the bariatric cohort, a finding that reached
nominal significance and in keeping with the consistent decreasing
trend in effect size with increasing BMI categories observed
(Table 3). Notably, a recent GWAS analysis demonstrated an
association of two deletions (43 kb and 8 kb) upstream of NEGR1
with early onset extreme obesity [22]. Importantly, these deletions
segregate on distinct haplotypes [9]. The rs2815752 SNP is known
to tag the 43 kb deletion [9], however the protective 8 kb deletion
is the major driver of the association with extreme obesity at the
NEGR1 locus and is tagged by an alternative SNP (rs1993709)
[22]. In this context, our findings suggest that the NEGR1
rs2815752 SNP contributes to the genetic risk of severe adult
obesity, likely driven by the alternative signal [22], but that the
Figure 1. The boxplot displays genetic risk scores in bariatric patients compared to normal-weight controls. The average genetic risk
score differentiated well between normal-weight controls group and the bariatric surgery group (P=8.3610211).
doi:10.1371/journal.pone.0070735.g001
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effects may be predominantly relevant at lower points on the
continuum of severe adult obesity. The comparable effects
observed in our study and data from Wheeler et al. [22] highlights
the important contribution of the NEGR1 locus to both adult and
early onset forms of severe obesity. However, further studies with
increased power are required to confirm our finding that, contrary
to the early onset form [22], there is a relatively smaller
contribution of the NEGR1 locus at the extreme tail of the severe
adult obesity spectrum. Of note, NEGR1 has been implicated in
hypothalamic control of body weight and food intake [39].
Evidence for a possible functional basis for the association effects
of variants at the NEGR1 locus have also been explored [22].
Evidence that the 8-kb deletion upstream of NEGR1 encompasses
a single binding site for a transcriptional repressor of NEGR1
begins to provide valuable insights into why these NEGR1 variants
are associated with severe obesity [22], however the downstream
mechanisms underlying the association remain to be elucidated.
The lower magnitudes of association with severe obesity found
for the other 12 BMI-increasing SNPs suggest that these loci exert
a smaller influence on the development of severe obesity.
However, power issues relating to the sample size of our study
Figure 2. Results of our logistic regression analysis were compared with the GIANT-extremes results using combined data from
obesity class 2 and 3 groups [11]; in terms of odds ratio (OR) with 95% confidence intervals (CI). There were no significant differences
between the compared OR. See Table 2 for allocated reference numbers of SNPs. The diagonal line represents the expected plotted values for our
results, based on the GIANT-extremes results. The SNPs below the diagonal line are those which had a larger effect in our study compared to GIANT-
extremes, whereas the SNPs above the diagonal line represent SNPs which had a larger effect in GIANT-extremes compared to our study.
doi:10.1371/journal.pone.0070735.g002
Table 1. Baseline demographic and clinical characteristics of
bariatric patients.
All UCLH UHP
Total number (n) 1,029 585 444
Excluded (n, %) 26 26 0
Included (n, %) 1,003 559 (56) 444 (44)
Age* (years) 44.6611 45.5610.8 43.5611.1
Female (%) 709 (71) 370 (66) 339 (76)
Male (%) 294 (29) 189 (34) 105 (24)
BMI* (kg/m2) 48.468.1 48.767.9 48.268.3
Type 2 diabetes (n, %) 260 (26) 157 (28) 104 (23)
Metabolic risk** (n, %) 583 (58) 299 (53) 284 (64)
Prev. bariatric surgery (n, %) 36 (4) 36 (6) 0 (0)
*Data are shown as mean 6 SD.
**Defined as presence of $1 major cardiovascular risk factor.
doi:10.1371/journal.pone.0070735.t001
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are likely to have impacted upon the strength of the associations.
Our finding that only 9 of the remaining 18 SNPs had effects
directionally consistent with the GIANT-BMI results [10] raises
the possibility that a proportion of SNPs that are associated with
BMI in the general population may not contribute to severe
obesity. This is in contrast with the data from the GIANT-
extremes analysis, in which the effects of all 32 BMI-associated loci
on all obesity-related traits were directionally consistent with the
prior study of adult BMI, although 4 SNPs were not at least
nominally associated with class 3 obesity [11]. However, it is
important to note that there is a considerable overlap between the
populations used for GIANT-extremes [11] and the prior GIANT-
BMI meta-analysis [10]. Our study was undertaken in an
independent cohort of patients with severe obesity, and this
methodological difference may account for our divergent findings.
There is also evidence from the recent study in the SCOOP cohort
(UK children of European ancestry with severe early-onset obesity,
n = 1,509) [22], that there is an incomplete overlap between loci
influencing obesity-related phenotypes among the general adult
population (GIANT) or early onset severe obesity (SCOOP). This
concept is supported by comparing results from case-control
studies of extreme obesity, including our findings, summarized in
Table S2 in File S1, suggesting that extreme obesity is a
heterogeneous disorder with varying genetic influences, both
shared and unshared across the spectrum. Nevertheless, in our
study, we did not find any significant differences between odds
ratios or effect sizes when compared with GIANT-extremes data
[11] (Figure 2) or GIANT-BMI data [10] (Figure 3A–B)
respectively. Therefore, the relatively small sample sizes in the
studies summarized in Table S2 in File S1 may have impacted
upon the strength of the associations with common BMI-
associated variants detected, in particular for risk alleles with
relatively lower frequencies such as the PRKD1 risk allele.
Interestingly, the sample size in our study compares well with
that of class 3 obesity in the GIANT-extremes study, drawn from a
pool of over 260,000 individuals, highlighting the productive
potential for undertaking genetic studies in patients attending
bariatric centres.
There are a number of potential limitations pertaining to our
study, chief amongst them is the lack of a ‘hypothesis-free’ study
design. Our results should be interpreted with caution, in this
regard, as our research question may have introduced a bias into
the findings. Furthermore, our study did not address other genetic
factors such as highly penetrant rare variants, that may exert an
increasing contribution in more extreme obesity and therefore
contribute to the ‘missing heritability’ of BMI-related phenotypes
[12]. For example, the recent genome-wide copy number variation
(CNV) analysis again in the SCOOP cohort demonstrated a
higher burden of rare, and in particular, singleton CNVs in the
extreme obesity cohort compared to controls [22]. Furthermore,
we acknowledge that our study is insufficiently powered to
replicate findings for all BMI-associated loci, many of which were
identified only using sample sizes several orders of magnitude
higher than in our study [10]. However, the potential to replicate
some of the strongest signals remained and we were also able to
test if any known loci had stronger effects in such an extreme
obesity dataset compared to the published population-based data.
Our findings in relation to the modest effects of these specific
common BMI-associated variants, as aptly demonstrated in
Figure 1, are consistent with the well-documented gap between
explained variance due to common variants (,2%) and estimated
heritability (h2) of obesity (,40–70%) [12,13,40]. However, a
novel approach called genome-wide complex trait analysis
(GCTA) has yielded results that suggest there are a multitude of
low penetrance common variants, each with causal effects too
small to allow detection by GWAS, together accounting for up to
17% of the overall BMI variance [41], which has been further
corroborated by the GIANT-extremes polygene analysis [11].
Figure 3. Effect sizes (i.e. changes in BMI) within the bariatric cohort, calculated by using standardized BMI values were compared
with the known effect sizes derived from inverse standardized BMI values in the GIANT-BMI meta-analysis [10] (A), and by using
unstandardized BMI values (B). Of note, the FTO marker effect size plotted for the GIANT-BMI data relates to the SNP rs1558902 (SNP rs9939609
in our study). There were no statistically significant differences between the compared effect sizes. See Table 2 for allocated reference numbers of
SNPs.
doi:10.1371/journal.pone.0070735.g003
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Such a GCTA approach has also been undertaken in a recent
analysis of twin studies and revealed that 37% of BMI h2 could be
explained by the effects of multiple common SNPs [42]. An
additional consideration is that the heritability of severe obesity is
not as well delineated as for overweight and lower levels of obesity,
although familial aggregation of severe obesity is well documented
[40]. Many of the classical twin studies involve less obese
populations and are not directly generalizable to severe obesity
[7,8]. Gene-environment interactions are another potential
explanation for the unexplained heritability [40]. In this light,
while our results suggest that accumulation of common variants
predisposes to severe obesity, actual BMI in adults with severe
obesity may be relatively more dictated by other factors including
environmental influences [43], compared to individuals in lower
BMI categories.
In summary, we have demonstrated that, among 32 BMI-
increasing common variants, at least 2 are strongly associated and
12 other variants are nominally associated with severe obesity in
patients attending a bariatric surgery centre. Combination of all 32
genotyped SNPs in a genetic risk score was associated with severe
obesity, however the risk score was not associated with actual BMI
within the bariatric cohort. We conclude that significant effects of
individual BMI-associated common variants can be found even in
a relatively small sample size, in a comparison of a bariatric cohort
to normal-weight controls, and that the burden of such low-
penetrant risk alleles contributes to severe obesity in this
population. These findings add more support to the hypothesis
that severe obesity represents an extreme tail of the population
BMI variation. However, the limitations of our study prevent us
from drawing any conclusions regarding the relative importance of
common genetic variants compared to other factors, genetic or
Table 2. Results of logistic regression for the 32 genotyped SNPs.
#Ref Nearest gene Chr rsid EA EAF cases EAF controls b P OR
#1 NEGR1 1 rs2815752 A 0.67 0.59 0.25 3.661024 1.29
#2 PTBP2 1 rs1555543 C 0.57 0.60 20.12 0.08 0.88
#3 SEC16B 1 rs543874 G 0.22 0.21 0.17 0.04 1.19
#4 TNNI3K 1 rs1514175 A 0.45 0.41 0.18 0.01 1.19
#5 FANCL 2 rs887912 T 0.32 0.29 0.13 0.09 1.14
#6 LRP1B 2 rs2890652 C 0.16 0.14 0.23 0.02 1.26
#7 RBJ 2 rs713586 C 0.48 0.49 20.004 0.95 0.996
#8 TMEM18 2 rs2867125 C 0.84 0.81 0.26 0.005 1.29
#9 CADM2 3 rs13078807 G 0.22 0.19 0.14 0.11 1.15
#10 ETV5 3 rs9816226 T 0.83 0.81 0.17 0.07 1.18
#11 GNPDA2 4 rs10938397 G 0.45 0.41 0.16 0.02 1.17
#12 SLC39A8 4 rs13107325 T 0.09 0.07 0.35 0.008 1.42
#13 FLJ35779 5 rs2112347 T 0.62 0.63 20.07 0.36 0.93
#14 NUDT3 6 rs206936 G 0.23 0.19 0.07 0.44 1.07
#15 TFAP2B 6 rs987237 G 0.20 0.17 0.22 0.02 1.24
#16 LRRN6C 9 rs10968576 G 0.27 0.31 20.003 0.97 0.997
#17 BDNF (B,M) 11 rs10767664 A 0.78 0.77 0.16 0.06 1.17
#18 MTCH2 11 rs3817334 T 0.42 0.41 0.06 0.41 1.06
#19 RPL27A 11 rs4929949 C 0.46 0.52 20.06 0.36 0.94
#20 FAIM2 12 rs7138803 A 0.40 0.36 0.21 0.004 1.23
#21 MTIF3 13 rs4771122 G 0.23 0.22 0.09 0.27 1.10
#22 OLFM4 13 rs9568856 A 0.14 0.12 0.25 0.02 1.28
#23 NRXN3 14 rs10150332 C 0.21 0.21 0.16 0.06 1.18
#24 PRKD1 14 rs11847697 T 0.06 0.04 0.44 0.007 1.55
#25 MAP2K5 15 rs2241423 G 0.75 0.77 20.05 0.56 0.95
#26 FTO 16 rs9939609 A 0.49 0.38 0.38 9.261028 1.47
#27 SH2B1 16 rs7359397 T 0.33 0.39 20.14 0.05 0.87
#28 HOXB5 17 rs9299 T 0.64 0.66 20.09 0.2 0.91
#29 MC4R (B) 18 rs571312 A 0.27 0.22 0.22 0.007 1.24
#30 KCTD15 19 rs29941 G 0.71 0.67 0.17 0.02 1.19
#31 QPCTL 19 rs2287019 C 0.84 0.81 0.16 0.08 1.17
#32 TMEM160 (Q) 19 rs3810291 A 0.66 0.68 20.12 0.12 0.89
#Ref, reference number of SNPs allocated for Figures 2 and 3; Chr, chromosome; rsid, reference SNP identification number; EA, Effect allele, i.e, BMI-increasing allele as
reported in the GIANT-BMI meta-analysis; EAF, effect allele frequency; b; effect size; OR, odds ratio.SNPs yielding at least nominal evidence for association are
highlighted in bold and SNPs with effect direction inconsistent with GIANT-BMI results are highlighted in italics.
doi:10.1371/journal.pone.0070735.t002
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otherwise, that are likely to contribute to severe obesity.
Nevertheless, future genetic studies focused on bariatric patients
may provide valuable insights into the pathogenesis of obesity at a
population level.
Supporting Information
File S1 Model S1. Formula for standardization of BMI values.
Model S2. Model used for calculation of genetic risk score. Table
S1. Comparison of additive, dominant and recessive models for
logistic regression analysis. Table S2. Comparison of case-control
analysis results (odds ratios) in 6 cohorts of extreme obesity for
common BMI-associated loci.
(DOCX)
Acknowledgments
We acknowledge use of data generated using the British 1958 Birth Cohort
collection. We would also like to thank the members of the University
College London Hospital Bariatric Group past and present for their
assistance with patient recruitment and management.
Author Contributions
Conceived and designed the experiments: RLB CML MIM SM RM.
Performed the experiments: SM AY AP EK GQ CP RM FS. Analyzed the
data: RM CML MIM SM RLB. Contributed reagents/materials/analysis
tools: RLB RM CML MIM. Wrote the paper: SM RLB RM CML MIM.
Reviewed the manuscript: RM SM AY AP FS EK GQ CP MIM CML.
Edited the manuscript: RM SM CML MIM RLB. Contributed to data
acquisition: SM AY AP EK FS EK GQ CP. Contributed to study design:
SM AY.
References
1. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, et al. (2011)
National, regional, and global trends in body-mass index since 1980: systematic
analysis of health examination surveys and epidemiological studies with 960
country-years and 9.1 million participants. Lancet 377: 557–567.
2. Sturm R, Hattori A (2012) Morbid obesity rates continue to rise rapidly in the
United States. Int J Obes (Lond).2012/09/19 ed.
3. UK Health and Social Care Information Centre website. Available: www.ic.nhs.
uk/pubs/hse11report. Accessed 2013 July 1.
4. Neovius M, Teixeira-Pinto A, Rasmussen F (2008) Shift in the composition of
obesity in young adult men in Sweden over a third of a century. Int J Obes
(Lond) 32: 832–836.
5. Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and
trends in the distribution of body mass index among US adults, 1999–2010.
JAMA 307: 491–497.
6. Andreyeva T, Sturm R, Ringel JS (2004) Moderate and severe obesity have large
differences in health care costs. Obes Res 12: 1936–1943.
7. Silventoinen K, Rokholm B, Kaprio J, Sorensen TI (2010) The genetic and
environmental influences on childhood obesity: a systematic review of twin and
adoption studies. Int J Obes (Lond) 34: 29–40.
8. Maes HH, Neale MC, Eaves LJ (1997) Genetic and environmental factors in
relative body weight and human adiposity. Behav Genet 27: 325–351.
9. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, et al. (2009) Six new loci
associated with body mass index highlight a neuronal influence on body weight
regulation. Nat Genet 41: 25–34.
10. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, et al. (2010)
Association analyses of 249,796 individuals reveal 18 new loci associated with
body mass index. Nat Genet 42: 937–948.
11. Berndt SI, Gustafsson S, Magi R, Ganna A, Wheeler E, et al. (2013) Genome-
wide meta-analysis identifies 11 new loci for anthropometric traits and provides
insights into genetic architecture. Nat Genet.2013/04/07 ed.
12. Hebebrand J, Volckmar AL, Knoll N, Hinney A (2010) Chipping away the
‘missing heritability’: GIANT steps forward in the molecular elucidation of
obesity - but still lots to go. Obes Facts 3: 294–303.
13. Xia Q, Grant SF (2013) The genetics of human obesity. Ann N Y Acad
Sci.2013/01/31 ed.
14. Bradfield JP, Taal HR, Timpson NJ, Scherag A, Lecoeur C, et al. (2012) A
genome-wide association meta-analysis identifies new childhood obesity loci. Nat
Genet 44: 526–531.
15. Zhao J, Bradfield JP, Zhang H, Sleiman PM, Kim CE, et al. (2011) Role of BMI-
associated loci identified in GWAS meta-analyses in the context of common
childhood obesity in European Americans. Obesity (Silver Spring) 19: 2436–
2439.
16. Cotsapas C, Speliotes EK, Hatoum IJ, Greenawalt DM, Dobrin R, et al. (2009)
Common body mass index-associated variants confer risk of extreme obesity.
Hum Mol Genet 18: 3502–3507.
17. Haworth CM, Plomin R, Carnell S, Wardle J (2008) Childhood obesity: genetic
and environmental overlap with normal-range BMI. Obesity (Silver Spring) 16:
1585–1590.
18. Day FR, Loos RJ (2011) Developments in obesity genetics in the era of genome-
wide association studies. J Nutrigenet Nutrigenomics 4: 222–238.
19. Wang K, Li WD, Zhang CK, Wang Z, Glessner JT, et al. (2011) A genome-wide
association study on obesity and obesity-related traits. PLoS One 6: e18939.
20. Meyre D, Delplanque J, Chevre JC, Lecoeur C, Lobbens S, et al. (2009)
Genome-wide association study for early-onset and morbid adult obesity
identifies three new risk loci in European populations. Nat Genet 41: 157–159.
21. Scherag A, Dina C, Hinney A, Vatin V, Scherag S, et al. (2010) Two new Loci
for body-weight regulation identified in a joint analysis of genome-wide
association studies for early-onset extreme obesity in French and german study
groups. PLoS Genet 6: e1000916.
22. Wheeler E, Huang N, Bochukova EG, Keogh JM, Lindsay S, et al. (2013)
Genome-wide SNP and CNV analysis identifies common and low-frequency
variants associated with severe early-onset obesity. Nat Genet.2013/04/07 ed.
23. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, et al. (2007) Effects
of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:
741–752.
Table 3. Association results with FTO SNP rs9939609 and NEGR1 SNP rs2815752 in categories of BMI, compared with normal-
weight controls.
BMI Categories (kg/m2) 35.0–39.9 40.0–44.9 45.0–49.9 50.0–59.9 $60.0
FTO SNP
n 116 237 270 246 84
P 0.1 0.01 0.002 0.047 3.461026
b 0.35 0.35 0.40 0.26 1.08
SE 0.21 0.14 0.13 0.13 0.23
NEGR1 SNP
n 116 239 266 250 83
P 0.11 0.01 0.08 0.07 0.93
b 0.32 0.33 0.22 0.22 0.02
SE 0.20 0.13 0.12 0.12 0.22
b, effect size; SE, standard error.
doi:10.1371/journal.pone.0070735.t003
Genetics of Obesity in Bariatric Surgery Patients
PLOS ONE | www.plosone.org 8 August 2013 | Volume 8 | Issue 8 | e70735
24. Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011.
Obes Surg 23: 427–436.
25. International Parkinson’s Disease Genomics Consortium and Wellcome Trust
Case Control Consortium 2 (2011) A two-stage meta-analysis identifies several
new loci for Parkinson’s disease. PLoS Genet 7: e1002142.
26. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, et al. (2009)
Genome-wide association study and meta-analysis find that over 40 loci affect
risk of type 1 diabetes. Nat Genet 41: 703–707.
27. Wellcome Trust Case Control Consortium (2007) Genome-wide association
study of 14,000 cases of seven common diseases and 3,000 shared controls.
Nature 447: 661–678.
28. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second
generation human haplotype map of over 3.1 million SNPs. Nature 449: 851–
861.
29. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007)
PLINK: a tool set for whole-genome association and population-based linkage
analyses. Am J Hum Genet 81: 559–575.
30. Marchini J, Howie B, Myers S, McVean G, Donnelly P (2007) A new multipoint
method for genome-wide association studies by imputation of genotypes. Nat
Genet 39: 906–913.
31. R project website. Available: http://www.R-project.org. Accessed 2013 July 1.
32. Mitchell JA, Hakonarson H, Rebbeck TR, Grant SF (2013) Obesity-
susceptibility loci and the tails of the pediatric BMI distribution. Obesity (Silver
Spring).2013/02/15 ed.
33. Dina C, Meyre D, Gallina S, Durand E, Korner A, et al. (2007) Variation in
FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39:
724–726.
34. Hinney A, Nguyen TT, Scherag A, Friedel S, Bronner G, et al. (2007) Genome
wide association (GWA) study for early onset extreme obesity supports the role of
fat mass and obesity associated gene (FTO) variants. PLoS One 2: e1361.
35. Timpson NJ, Emmett PM, Frayling TM, Rogers I, Hattersley AT, et al. (2008)
The fat mass- and obesity-associated locus and dietary intake in children.
Am J Clin Nutr 88: 971–978.
36. Tung YC, Ayuso E, Shan X, Bosch F, O’Rahilly S, et al. (2010) Hypothalamic-
specific manipulation of Fto, the ortholog of the human obesity gene FTO,
affects food intake in rats. PLoS One 5: e8771.
37. Bell CG, Finer S, Lindgren CM, Wilson GA, Rakyan VK, et al. (2010)
Integrated genetic and epigenetic analysis identifies haplotype-specific methyl-
ation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS One 5:
e14040.
38. Almen MS, Jacobsson JA, Moschonis G, Benedict C, Chrousos GP, et al. (2012)
Genome wide analysis reveals association of a FTO gene variant with epigenetic
changes. Genomics 99: 132–137.
39. Lee AW, Hengstler H, Schwald K, Berriel-Diaz M, Loreth D, et al. (2012)
Functional inactivation of the genome-wide association study obesity gene
neuronal growth regulator 1 in mice causes a body mass phenotype. PLoS One
7: e41537.
40. Drong AW, Lindgren CM, McCarthy MI (2012) The genetic and epigenetic
basis of type 2 diabetes and obesity. Clin Pharmacol Ther 92: 707–715.
41. Yang J, Manolio TA, Pasquale LR, Boerwinkle E, Caporaso N, et al. (2011)
Genome partitioning of genetic variation for complex traits using common
SNPs. Nat Genet 43: 519–525.
42. Llewellyn CH, Trzaskowski M, Plomin R, Wardle J (2013) Finding the missing
heritability in pediatric obesity: the contribution of genome-wide complex trait
analysis. Int J Obes (Lond).2013/03/27 ed.
43. Sharma AM, Padwal R (2010) Obesity is a sign - over-eating is a symptom: an
aetiological framework for the assessment and management of obesity. Obes Rev
11: 362–370.
Genetics of Obesity in Bariatric Surgery Patients
PLOS ONE | www.plosone.org 9 August 2013 | Volume 8 | Issue 8 | e70735
